Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Apollo Neuroscience, Inc.

Apollo Neuroscience, Inc.

Stage unknownPittsburgh, PAOther Health Care
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
2 rounds
  1. Apr 15, 2024
    Form D equity offering · $500,000 (form d sold) · 1 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Apollo Neuroscience, Inc. filed Form D: $500,000 sold of $2,000,000, Other Health Care”
  2. Feb 9, 2023
    Form D equity offering · $9.3M (form d sold) · 17 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Apollo Neuroscience, Inc. filed Form D/A: $9,270,041 sold of $15,000,000, Other Health Care”
Investors on record
1 edges
People
3 officers, 2 directors
Timeline
2
  1. Apr 30, 2024
    Apollo Neuroscience, Inc. filed Form D: $500,000 sold of $2,000,000, Other Health Care
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Apr 29, 2024
    Apollo Neuroscience, Inc. filed Form D/A: $9,270,041 sold of $15,000,000, Other Health Care
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
28 observations
Every observation on this company